BIOMARKER FOR PREDICTION OF CHEMOTHERAPY-INDUCED NEUROPATHY

A prediction device is configured to perform a prediction method to predict a risk of chemotherapy-induced peripheral neuropathy, CIPN, in a test subject. The prediction method comprises receiving (211) perception data comprising low-frequency vibration perception data, LF-VPD, and operating (214) at least one prediction model on the perception data to determine at least one risk variable, which is indicative of a risk that the test subject will develop peripheral neuropathy as a result of chemotherapy. The LF-VPD designates measured perception of vibrations at one or more predetermined locations on one or more limbs of the test subject, and represents, for vibrations at each of one or more predefined frequencies below 64 Hz, a vibration energy that causes the test subject to switch between perception and non-perception of the vibrations.